Localized Acetylcholine Receptor Clustering Dynamics in Response to Microfluidic Focal Stimulation with Agrin  by Tourovskaia, Anna et al.
Localized Acetylcholine Receptor Clustering Dynamics in Response to
Microﬂuidic Focal Stimulation with Agrin
Anna Tourovskaia, Nianzhen Li, and Albert Folch
Department of Bioengineering, University of Washington, Seattle, Washington
ABSTRACT Agrin is a proteoglycan secreted by the motor neuron’s growing axon terminal upon contact with the muscle
during embryonic development. It was long thought that agrin’s role was to trigger the clustering of acetylcholine receptors
(AChRs) to nascent synapse sites. However, agrin-predating, protosynaptic AChR clusters are present well before innervation
in the embryo and in myotube cultures, yet no role has been conclusively ascribed to agrin. We used a microﬂuidic device to
focally deliver agrin to protosynaptic AChR clusters in micropatterned myotube cultures. The distribution of AChRs labeled with
ﬂuorescent bungarotoxin was imaged at various time points over .24 h. We ﬁnd that a 4-h focal application of agrin (100 nM)
preferentially reduces AChR loss at agrin-exposed clusters by 17% relative to the agrin-deprived clusters on the same myotube.
In addition, the focal application increases the addition of AChRs preferentially at the clusters by 10% relative to the agrin-
exposed, noncluster areas. Taken together, these ﬁndings suggest that a focal agrin stimulus can play a key stabilizing role in
the aggregation of AChRs at the early stages of synapse formation. This methodology is generally applicable to various
developmental processes and cell types, including neurons and stem cells.
INTRODUCTION
Proper development of the nervous system relies on the
delicately coordinated formation of synapses (1), which must
occur at precise locations and times. Experimental interro-
gation of the synaptogenesis process in vivo is extremely
difﬁcult. Because genetic engineering of key molecules is
often embryonically lethal and physical access to the synaptic
site can disrupt synapse formation irreversibly. Even the
formation of the neuromuscular synapse, the best studied
synapse due to its relatively straightforward anatomical ac-
cessibility (1), is still not fully understood. In general, in vitro
studies of embryonic development face great technological
challenges, as development is a highly dynamic process that
involves myriad signaling factors varying across subcellular
length scales and at subminute timescales. Microtechnologies
such as microﬂuidics and surface patterning offer a great
potential for recreating physiological conditions by deliver-
ing signaling factors to the cells in physiologically mean-
ingful spatial distributions and at a precise differentiation
state. We have developed a microdevice that allows us to
partially mimic the innervation of a muscle cell by a neuron.
A functional neuromuscular synapse consists of a high
postsynaptic density of acetylcholine receptors (AChRs) (2).
A highly dynamic AChR clustering mechanism, initiated
during development, keeps the synaptic surface density of
AChRs several orders-of-magnitude higher than at the ex-
trasynaptic sites (2,3); AChRs form aggregates at nerve-
contacted sites as well as spontaneously (4,5), and AChRs
that do not associate with the nerve terminal eventually dis-
appear (6–9). It was long thought that AChR clustering at the
nascent synapse was triggered by the proteoglycan agrin (the
agrin hypothesis (10)), which is secreted by the nerve ter-
minal upon and/or during innervation (2,10,11) (Fig. 1 A).
Unfortunately, in vivo it is not possible to artiﬁcially stimu-
late AChR clusters with agrin focally due to diffusion.
The observation that traditional myotube cultures form
punctate microclusters of AChRs upon bath or focal appli-
cation of agrin or an agrin fragment (see Fig. S1, A and B, in
Supplementary Material) was thought to be supportive of the
agrin hypothesis. Past efforts to mimic in vitro the nerve’s
local delivery of agrin have used focal stimulation with beads
(12), agrin micropatterns (13), or co-cultures with agrin-
producing cells (12), but could not (or did not) address pro-
tosynaptic AChR clusters (12,13) and could not control the
location and/or timing of the focal stimulus (7,12,13). In the
past, we have reported a microﬂuidic device that uses laminar
ﬂow to locally deliver biochemicals to a user-selected portion
of an array of single myotubes cultured orthogonally to the
ﬂow (14,15). Focal agrin stimulation of myotubes seeded on
ﬁbronectin surfaces resulted in formation of microclusters in
the stimulated areas, both in micropatterned (16) as well as in
randomly-oriented myotubes (17) seeded on ﬁbronectin
surfaces.
Recently, however, imaging of embryos (both in mouse
(18–20) and Zebraﬁsh (8,21)) has revealed that large proto-
synaptic AChR aggregates of normal synaptic morphology
form on the muscle membrane before the arrival of the nerve
(Fig. 1 A). MuSK, a receptor tyrosine kinase activated by
agrin, is required for the formation of the protosynaptic
AChR clusters even though agrin is not (18). What is, then,
the role of agrin, given that it is not the cause of AChR
clustering? One possibility is that it acts to stabilize the ex-
isting clusters (although the nerve can also make synapses in
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regions where aneural AChR clusters do not form (5)). In
support of this hypothesis, the agrin-predating protosynaptic
clusters are stabilized if found by the nerve but dissolve if not
innervated. An additional role of agrin appears to be to
counteract the declustering action of acetylcholine (ACh),
since synapses form in the absence of agrin provided that
ACh is also absent (7). While these results add to challenge
the agrin hypothesis, they do not conclusively attribute any
speciﬁc synaptogenic role to agrin. Here we sought to address
the fundamental question of how protosynaptic AChR clus-
ters evolve upon local exposure to soluble agrin.
We used a microdevice to interrogate how, in the absence
of neurotransmitter action, agrin-predating AChR clusters
evolve upon local exposure to agrin in myotube cultures.
After ﬂuorescently labeling the AChR clusters, the ﬂuores-
cence stability of agrin-exposed and agrin-deprived domains is
compared. We observe that a short (4 h) focal application of
agrin slows down the loss of AChRs from those clusters rela-
tive to the agrin-deprived clusters. Based on one relabeling at
the end of the experiment (24–25 h), we observe that AChR
addition is highest at the agrin-exposed clusters. Thus, agrin,
at least in vitro, acts to selectively reduce and increase AChR
loss and addition, respectively.
MATERIALS AND METHODS
Microﬂuidic device
Standard soft lithographic techniques were used to fabricate the device in
poly(dimethylsiloxane) (PDMS) by replica molding from a microfabricated
master; the design, fabrication, and operation of the device is described in
detail elsewhere (14). The glass substrate was chemically micropatterned to
restrict the areas available for cell attachment and myotube formation (22).
Micropatterns of cell-adhesive tracks (PDL/Matrigel on glass) separated by a
cell-repellent graft of polyethylene glycol were prepared using oxygen plasma
etching and PDMS microchannels as masks, as reported previously (15,22).
Microﬂuidic myotube microarray culture
Microﬂuidic long-term cultures of micropatterned myotubes are described in
detail elsewhere (19,23). Brieﬂy, C2C12 myoblasts (ATCC, Manassas, VA)
were cultured in tissue culture grade dishes before passage 10 in DMEM
(Life Technologies, Bethesda, MA), supplemented with 20% fetal bovine
serum (HyClone, Logan, UT) and 1% penicillin-streptomycin (Life Tech-
nologies), and maintained in a humidiﬁed incubator at 37C with 10% CO2.
The cell suspension was injected into the microﬂuidic devices at;2,000,000
cells/mL, and cells were allowed to attach and spread on the Matrigel-coated
microtracks for 15–30 min before continuous perfusion from side channels
was established. Fusion into myotubes was promoted at conﬂuence (the day
after seeding) by low-serum differentiating medium (DM) consisting of 5%
horse serum (ATCC) and 1% penicillin-streptomycin-fungizone in DMEM.
Myotubes formed in the device within 1 week after switching to DM.
Agrin stimulation
Localized stimulation was performed as discussed in detail elsewhere (14,15).
Agrin (C-terminal fragment, C-Ag3,4,8) was purchased from R&D Systems
(Minneapolis, MN) and used at 100 nM ﬁnal concentration. In localized-agrin
experiments four laminar ﬂow streams (three carrying DM and one carrying
100 nM agrin inDM)were ﬂowed through the device at a velocity of 240mm/s
for 4 h. Shear stresses associated with such velocities were not observed to
noticeably affect C2C12 cell viability, morphology, growth, or differentiation
(15). After agrin ﬂow was stopped, cells were washed and incubated in agrin-
freemedium over two days and imaged at selected time points (Fig. 2A). Agrin
ﬂow was visualized during the experiment by adding Allura Red food dye (1
mg/ml) in the agrin-containing stream. We have not observed any obvious
deleterious effects derived from the exposure of the myotubes to Allura at that
concentration. Allura also had no AChR-aggregating effect (15,16). Because
FIGURE 1 Synaptogenesis on a chip. (A) During development, neurons
release agrin at the site of contact between nerve and muscle. (B) Fluores-
cence micrograph of a portion of the myotube microarray after staining the
AChRs with Alexa Fluor 488-conjugated a-bungarotoxin (BTX*). Scale bar
is 50 mm. (C) Three high-magniﬁcation ﬂuorescence micrographs of
myotubes stained with BTX*, showing that aneural AChR clusters display
intricate shapes similar to those found in vivo. (D) Phase-contrast micro-
graph of the microﬂuidic device containing a ladder micropattern of
myotubes during stimulation by a laminar stream of agrin (spiked with red
Allura dye for visualization). The black-dashed box corresponds to the area
shown in panel B.
3010 Tourovskaia et al.
Biophysical Journal 95(6) 3009–3016
ﬂuorescent tagging of agrin is not practical and could affect agrin signaling, we
quantiﬁed the agrin (molecular mass ;90 kDa) proﬁle using ﬂuorescently-
conjugated BSA (Texas Red BSA, molecular mass ;70 kDa) (BSA*) at the
end of each experiment. The width of the agrin stream during focal stimulation
can be inferred from the width of the BSA* stream (Fig. 2 B) because the
diffusion coefﬁcient D is insensitive to changes in molecular weight, D ;
(MW)1/3, and the mean diffusive path x is not very sensitive to changes in D
(x ; D1/2) (24). AChR clusters that fell within .10% of the BSA* peak
intensity were considered to be agrin-exposed and the clusters that fell outside
of that area were considered to be agrin-deprived.
Imaging
Fluorescence and phase-contrast images were acquired on an inverted mi-
croscope (Nikon Eclipse TE2000-U; Nikon, Melville, NY) with a cooled
charge-coupled device camera (ORCA-HR; Hamamatsu Photonics, Hama-
matsu City, Japan) using commercial imaging software (MetaMorph; Uni-
versal Imaging, Downingtown, PA). Care was taken to minimize the
photobleaching by keeping illumination intensity at low levels. Exposure
times, camera offset, and gain settings were kept constant for all images on all
days. To cover the entire channel width, two overlapping images were taken
(a few seconds apart) at each time point and processed separately. There are
;60 myotubes per device, of which we only consider the upstream two-
thirds for analysis, to avoid confounding effects by agrin stream broadening
downstream. Themicroscope’s ﬁeld of view ﬁts only three half-myotubes, so
for each experiment 14 pairs of side-by-side images were acquired, each pair
spanning in width the length of a myotube (i.e., the width of the device).
Thus, each experiment yielded data on;42 myotubes. Only myotubes with
clusters on the agrin-exposed areas were chosen for analysis (N ¼ 23, N ¼
15, and N ¼ 10 for experiments 1, 2, and 3). The cells were returned to a
standard tissue culture incubator after each imaging session.
Labeling of cells
Myotubes were labeled with Alexa 488-conjugated a-bungarotoxin (BTX*)
at 5 mg/ml for 1 h to saturate all AChRs (25), washed in phenol red-free DM,
and imaged (time-point 0 h). Cells were then exposed to agrin for 4 h,
washed, and imaged again (time-point 4 h). Finding the same area was
straightforward because cells were arranged in micropatterns. The cells were
reimaged again at 8, 10, 20, and 24 h (Fig. 2 A). Finally, after taking the 24-h
time-point image, the AChRs were relabeled to saturation and the cells were
reimaged 1 h (25-h time-point) later to assess the total AChR density. We
also assessed the rate of photobleaching of BTX* bound to the AChR
clusters. Labeled myotubes were ﬁxed, imaged, and immediately reimaged;
the ﬂuorescence loss resulting from photobleaching was found to be ,1%
between sequential images. In principle, we cannot rule out the possibility
that (labeled) internalized AChRs or (unquenched) free Alexa dye (from
degraded AChRs) in the cytoplasm contribute to the ﬂuorescence intensity of
the myotube (i.e., both nonclustered and clustered AChR areas) and partially
confound AChR distribution changes. However, since the clusters occupy
only ;6–7% of the myotube membrane, and the density in the clusters is at
the most only ;3 times that of the noncluster areas, internalized clustered
receptors (which, in addition, go out of focus) are unlikely to contribute
signiﬁcantly to the ﬂuorescence signal. Also, the ﬂuorescence of Alexa 488
(that is, stable at lysosomal pH) can be quenched by denaturing BTX (26). In
any case, the cellular origin of the background ﬂuorescence is relevant to the
measurements of the stability of noncluster areas but is irrelevant to the
conclusion that agrin reduces the loss and increases the addition of AChRs at
cluster areas relative to their surroundings. See Data S1 in Supplementary
Material for a detailed explanation of the image analysis.
RESULTS
Microﬂuidic focal agrin stimulation
As a quantitative model of the selective exposure of the
myotube membrane to agrin in vivo (Fig. 1 A), we have de-
veloped a microﬂuidic device that delivers agrin selectively
to a user-selected portion of an array of .60 single, parallel
myotubes cultured orthogonally to the ﬂow (14). We use a
well-characterized in vitro model of muscle cell differentia-
tion based on C2C12 myoblast cultures, which fuse to form
functional myotubes (27,28). We use the recombinant
C-terminal neural agrin fragment, which is known to potently
induce punctate AChR clusters in myotube cultures under
bath (29) and focal (16) application.
Before agrin delivery, isolated myotubes already display
several (;8 6 5.5 per myotube) intricately-shaped proto-
FIGURE 2 Focal application of agrin
onto aneural AChR clusters. (A) Sche-
matic of the experimental design show-
ing the application of ﬂuorescent AChR
label (BTX*, green vertical arrows) and
of agrin with the imaging times (camera
icons). (B) Fluorescence micrograph
(false color) of the stream of a ﬂuores-
cent agrin tracer (Texas Red-conjugated
BSA) taken at the end of the experiment,
which serves to extrapolate the agrin
concentration proﬁle (see Data S1).
Overlaid is a line scan (red curve) across
the micrograph; clusters are considered
exposed to agrin if they are in an area
exposed to at least 10% of the maximal
agrin concentration, and agrin-deprived
otherwise. For reference, red dashed
lines denote 50% of maximal agrin
concentration. (C) Fluorescence BTX*
staining of the same area as in panel B, showing three myotubes across the device. Scale bar is 50 mm. (D) Time evolution of the two areas boxed in panel C
from the same myotube. The myotubes were labeled with BTX* right before t¼ 0 h and right after the t¼ 24 h time-point image. Cells were focally exposed to
agrin (0–4 h) and imaged at the indicated time points. Scale bar is 25 mm.
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synaptic AChR clusters as revealed by the permanent AChR
label a-bungarotoxin (BTX) conjugated with Alexa Fluor
488 (BTX*). As shown in Fig. 1, B and C, AChR clusters of
complex morphologies (strikingly similar to those found in
vivo) can, too, form in vitro in the absence of agrin if the
myotubes are cultured on micropatterns of the basal lamina
extract Matrigel (Fig. S1, C and D for diversity of morphol-
ogies), whether inside or outside a device. Nonmicropatterned
myotubes also display agrin-independent AChR clusters on
Matrigel (Fig. S1 E) and on laminin (23,30), but not on a ﬁ-
broblast feeder layer (Fig. S1 F).
The device is fabricated by micromolding of a transparent
elastomer, PDMS, and assembled onto an array of 25 mm-
wide linear tracks of dried Matrigel on glass that are separated
by a polyethylene-glycol graft nonadherent to cells (15,22). As
a result, C2C12 cells introduced inside the device proliferate
and fuse (over ;1 week) into myotubes only on the Matrigel
tracks, forming a ladder of single myotubes (Fig. 1 D) (14).
Only one of the inlets is ﬁlled with agrin, so that under laminar
ﬂow conditions typical of microchannels (i.e., no turbulence),
the fraction of each myotube exposed to a given concentration
of agrin can be inferred from the spatial distribution of a dye
added to the agrin solution (16) (see below).
As shown in the Fig. 2 A schematic, in a typical experiment
the myotubes were:
1. Labeled with BTX* and immediately imaged, which
deﬁned time t ¼ 0.
2. Exposed to agrin from 0 to 4 h.
3. Imaged by ﬂuorescence microscopy at t ¼ 4, 8, 10, 20,
and 24 h.
4. Relabeled at 24 h to assess the addition of new AChRs;
and
5. Imaged at 25 h.
The agrin stream’s position was visualized during the
experiment by adding to the agrin-containing stream a food-
coloring dye (Allura Red, 1 mg/ml) (Fig. 1 D), and the con-
centration proﬁle was measured after the experiment by
adding ﬂuorescently-labeled bovine serum albumin (BSA)
(of diffusivity similar to that expected of agrin; see Data S1)
(Fig. 2 B). Fig. 2C shows the BTX*-staining of the same area
of the device as in Fig. 2 B, revealing some clusters in the
agrin path and some outside of it. We have not observed
deleterious or AChR-aggregating effects derived from the
exposure of the myotubes to the dyes alone at the concen-
trations used (16). The concentration proﬁle widens diffu-
sively downstream (with no discernible effect on the
conclusions of this study, see Fig. S3; only the upstream two-
thirds of the device are used for analysis). For simplicity of
analysis, agrin exposure is considered binary, i.e., exposed
to agrin (if exposed to at least 10% of the maximal agrin
concentration, or 100 nM at inlet) or deprived of agrin
(otherwise). A typical time sequence of agrin-exposed and
agrin-deprived (BTX*-stained) clusters is shown in Fig. 2 D
(left and right columns, respectively).
To measure AChR density, four types of regions are
identiﬁed and manually selected in each myotube, as shown
schematically in Fig. 3 A: regions A and C correspond to
AChR cluster areas exposed to and deprived of agrin, re-
spectively, whereas regions B and C correspond to the
myotube membrane background (adjacent to regions A
and C) exposed to and deprived of agrin, respectively. The
average ﬂuorescence intensity of each region is recorded over
time and background-corrected (Fig. S2), giving time func-
tions A(t), B(t), C(t), and D(t) for each myotube. Photo-
bleaching and BTX* binding to other components of the
membrane or the substrate are negligible in our ﬂuorescence
imaging setup, and the potential contribution from free ﬂuo-
rophore in the cytoplasm (after BTX*-AChR internalization
and degradation) can be ruled out (see Data S1); therefore,
the ﬂuorescence intensity after background correction is
approximately proportional to AChR density.
Focal agrin slows down AChR loss at
agrin-predating clusters
AChR density changes as a function of time can be qualita-
tively assessed from the averages A(t), B(t), etc., as shown in
Fig. 3 B from a representative experiment (N ¼ 23 myotubes,
;184 clusters). The AChR cluster areas A(t) and C(t) are
initially ;3 times brighter than their neighboring noncluster
areas B(t) and D(t), and over time the clusters fade (a sign of
AChR internalization and degradation (31)) while the non-
cluster areas remain approximately constant. (See Materials
and Methods and Data S1for the various contributions to the
ﬂuorescence signal, including diffuse and internalized recep-
tors or cytoplasmic Alexa dye.) The rate of decay for A(t) and
C(t) tapers off (;60% of the agrin-exposed and ;40% of the
agrin-deprived AChRs in the clusters still remain at t ¼ 24 h),
which hints at a density-dependent AChR loss process yield-
ing an exponential decay (i.e., governed by Michaelis-Menten
kinetics). However, the large variability in the A(t), B(t), etc.
makes it difﬁcult to ascertain more precise conclusions from
this graph.
A more quantitative analysis can be done by averaging all
the values of the ratios of the A(t), B(t), etc., for each myotube,
thus using each region as a reference point for measuring an-
other region’s ﬂuorescence; this ratiometric analysis based on
cellular-scale, internal controls is insensitive to variations in
the ﬂuorescence excitation lamp or in background myotube
membrane ﬂuorescence. The summary of the ratiometric
analysis for n ¼ 3 experiments (N ¼ 48 myotubes, ;384
clusters) is shown in Fig. 3, C and D. The data from the sep-
arate experiments is shown in different symbols (circles, tri-
angles, squares) to emphasize that the trends are almost exact
in each experiment. In other words, the error bars can be at-
tributed mostly to variability from experiment to experiment,
likely due to the accuracy of the ratiometric method. Fig. 3 C
conﬁrms that AChR density is;3 times larger and less stable
in cluster areas than in noncluster areas (i.e., both A(t)/B(t) and
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C(t)/D(t) are;3 at t¼ 0 and decay thereafter). By t¼ 20–24 h,
the agrin-exposed cluster areas A(t) are 21 6 5% on average
brighter than the agrin-deprived cluster areas C(t) (Fig. 3 D)
(i.e., receptor loss is 17% larger in agrin-deprived clusters C(t)
than in agrin-exposed clusters A(t) over the 24-h period), in-
dicating that the clustered receptors become more stable when
they are exposed to focal agrin.
The fact that both A(t)/B(t) and C(t)/D(t) decrease with B(t)
and D(t) constants means that clustered AChRs are less stable
than diffuse AChRs (whether they are exposed to agrin or not).
This ﬁnding counters the intuition that clustered receptors,
being more tightly associated, should be more stable than
nonclustered ones. Also, the agrin-caused difference between
A(t)/B(t) and C(t)/D(t) cannot be attributed to changes in ab-
solute B(t) or D(t) (which stay fairly constant; see Fig. 3 B).
Indeed, the plots in Fig. 3 D show how agrin signiﬁcantly
increases the stability of clustered AChRs (A(t)/C(t) increases)
but does not have a signiﬁcant effect on diffuse AChRs (B(t)/
D(t); ct.). Since B(t) andD(t) stay constant, we speculate that
the likeliest route for AChR loss is directly in the direction
orthogonal to the membrane (i.e., diffusive loss of receptors
from cluster to noncluster areas is minimal or very local).
Agrin increases AChR addition into
preexisting clusters
To measure AChR addition, we relabeled the AChRs with
BTX* after t ¼ 24 h (vertical green arrow in Fig. 2 D and in
Fig. 3 graphs) and imaged at t¼ 25 h; the two time points are
sufﬁciently close in time that the increase represents mainly
the addition of new (nonlabeled) AChRs to the clusters (be it
by insertion or by diffusion), i.e., we can safely neglect the
receptor loss within that 1-h period (especially since, at this
time, receptor loss has already slowed down signiﬁcantly).
Unfortunately, it was not possible to relabel with a different
color-BTX* at the time, so insertion of new AChRs and
diffusion of old AChRs could not be distinguished. The
largest increases at t ¼ 25 h (with respect to t ¼ 24 h time-
point values) were seen for A/B (9.9 6 5.5%, maximum
16.3% in experiment 1) and for A/C (7.46 5.0%, maximum
10.4% in experiment 1). C/D increases were an average of
5.2 6 3.2%, and the lowest increase was B/D (1.8 6 2.1%,
with 0.5% reduction in experiment 1). In other words, despite
the large ﬂuctuations there is a clear trend 10% ; DA/B .
DA/C . DC/D . DB/D ;0. Thus, we can conclude that our
4-h focal application of agrin caused a statistically signiﬁcant
preferential addition of AChRs at clusters (DA/B and DA/C
were largest) and small or no signiﬁcant increase at the dif-
fuse AChR areas (DB/D ;0).
DISCUSSION
The focally stimulated myotube micropattern layout has
several key advantages for studying AChR clustering over a
homogeneously-stimulated, random myotube culture (where
myotubes often overlap each other):
FIGURE 3 Local AChR density dynamics.
(A) Schematic representation of the four regions
that are deﬁned and marked for analysis: clus-
ter(s) and myotube background exposed to
agrin (regions A and B, respectively) and clus-
ter(s) and myotube background not exposed to
agrin (C and D, respectively); A and C are
typically comprised of several (range 2–16,
average 8 6 SD 5.5) individual clusters. After
labeling with a saturating dose of BTX* and
background correction, ﬂuorescence intensity in
a region X (X ¼ A, B, C, or D) is assumed to be
proportional to AChR density, termed X(t). (B)
Graph of the average ﬂuorescence intensities in
regions A–C and (values relative to the average
A(0) for all myotubes) in a representative ex-
periment containing N ¼ 23 myotubes. BTX*
was reapplied after t ¼ 24 h (green vertical
arrows) to visualize the total AChR density and
to assess AChR addition (the t¼ 24 h data point
for experiment 3 could not be obtained, so it
was conservatively taken to be equal to the t ¼
20 h data point, despite the additional 4 h of
degradation; this results in a lower estimate of
AChR addition upon relabeling). (C) AChR
density ratios (as indicated) as a function of
time for n ¼ 3 experiments (total N ¼ 48
myotubes).
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1. Single myotubes can be studied in isolation, avoiding
confounding cell-cell contact interactions with other
myotubes.
2. All the myotubes are straight and most of them of similar
length (;1800 mm), and are stimulated with agrin at the
same position relative to the myotube (albeit not with the
same concentration at any given myotube position), thus
avoiding confounding differences in cell-geometrical
effects.
3. Each myotube and cluster can be easily found repeatedly
during different imaging sessions as the cell culture is
switched from the microscope to the incubator and back
to the microscope.
4. Each experiment yields data on tens of myotubes simul-
taneously, providing rich statistics.
5. The spaces between myotubes provide a reference area
for ﬂuorescence background correction (see Image Anal-
ysis in Data S1and Fig. S2).
And, last but not least,
6. For any given myotube, it is possible to pick certain areas
of the myotube as a reference to measure the ﬂuorescence
intensity in other areas.
Also, it is noteworthy that a random culture ofmyotubes has an
unpredictable topology that induces chaotic mixing, which
accelerates diffusive broadening of the focal stream (defeating
the purpose of this study, data not shown); the orthogonal
orientation used here minimizes the topologically induced
enhanced mixing and allows for the focal stream to be at a
constant position with respect to the microchannel walls.
Bruneau et al. has shown that innervated AChR clusters in
mice are highly dynamic, with the AChRs continuously be-
ing degraded, inserted, and recycled (receptor recycling is
turned off when synaptic activity is blocked) (32). In agree-
ment with that work, our results suggest that AChR clusters
should not be considered frozen aggregates of AChRs, as
commonly depicted in textbooks, but instead, as boiling
spots. These localized high turnover rates may reﬂect a cel-
lular need for rapid synaptic reorganization that is particu-
larly intense during synaptogenesis. At the central nervous
system, a highly dynamic regulation of synaptic receptor
density is known to be crucial for synaptic plasticity (see
review (33)), so high receptor turnover may be a universal
feature of synaptogenesis both in central nervous system and
neuromuscular synapses. Our observations show that, at least
in vitro, the cell directs its AChR removal and additional
machinery with preference over the surrounding noncluster
areas in response to a focal application of agrin, although
agrin-predating clusters themselves may not be required for
synaptogenesis if the nerve happens to hit an area that does
not contain an aneural cluster (5). We postulate that, in this
model, agrin acts as a molecular tag that tells this machinery
when to slow down AChR loss and intensify AChR addition;
the aggregation of aneural clusters continually provides in-
nervation opportunities counteracting the AChR degrada-
tion/recycling mechanism that is essential for synaptic
maintenance. Without agrin, loss overcomes addition and the
cluster (if there to begin with) eventually disappears; with
agrin, the balance between addition and loss is tipped in favor
of AChR cluster survival. A thorough test of this hypothesis
will require exploring a wider range of experimental condi-
tions (e.g., several agrin doses) and competition experiments
(i.e., more than one agrin stimulus per myotube). In vivo, the
stabilizing effect of agrin might be cooperating with pre-
synaptic and basal lamina interactions to precisely match the
shape of AChR aggregates to the shape of the presynaptic
branches (observed in mice (7) and Zebraﬁsh (21)) before the
onset of activity. Importantly, this action of agrin does not
require neurotransmitter activity (unlike the previously de-
scribed antideclustering role of agrin that counteracts the
declustering action of ACh (7)). Preferential addition could
occur either via an unknown targeted transport mechanism
(insertion of newly-synthesized or recycled receptors (34)) or
indirectly by conferring adhesiveness to AChRs so that
clusters can constantly capture AChRs via in-membrane
diffusion (30). (We emphasize that, in our system, some new
microclusters form in the agrin-exposed areas (Fig. S4) that
may eventually contribute to the larger, agrin-independent
clusters.) Bruneau et al. (30) have used ﬂuorescence recovery
after photobleaching to show that lateral diffusion of AChRs
may account only for ;9% of all AChRs accumulated in a
given cluster within 8 h in myotubes not challenged with
agrin; recovery of AChRs by lateral diffusion was even
slower (twofold) when agrin was added to the myotube
cultures. This is known to occur at mature postsynaptic
AChR clusters in vivo (25). It has been proposed that the
scaffolding protein rapsyn, which links AChRs to the cyto-
skeleton (35) and reduces degradation of AChRs when the
stoichiometry of rapsyn to AChR is increased (36,37), may
intervene in the stabilization of AChRs by agrin.
Our ﬁnding that focal application of agrin increases AChR
addition to preexisting clusters agrees with previous ﬁndings
only partially. If addition by diffusion were negligible (al-
though it has been observed in C2C12 cultures accounting for
9% of AChR density recovery over 8 h (30)), our observation
would be in agreement with an earlier ﬁnding (not using
agrin) that AChR clusters display higher AChR insertion
rates than nonclustered AChRs (31). On the other hand,
Bruneau et al. (30) have studied AChR insertion (by re-
labeling with different colors) in C2C12 myotubes express-
ing protosynapse clusters upon agrin bath application and
found that AChRs insert mostly at noncluster locations (i.e.,
forming new microclusters); in comparison, we also see such
focal-agrin-induced microclusters upon relabeling at 25 h
(white arrows in Fig. S4), but addition is favored at clustered
locations and at agrin-exposed locations, i.e., DA/B andDA/C
are the largest increases. Experiments with two-color re-
labeling are underway to determine the relative contributions
of diffusion of oldAChRs and insertion of newAChRs in focal
agrin-induced addition of AChRs at protosynaptic clusters.
3014 Tourovskaia et al.
Biophysical Journal 95(6) 3009–3016
The clusters did not regain their initial density as shown by
relabeling with BTX* at the end of 25-h experiments, pos-
sibly reﬂecting that the clusters are in the process of disas-
sembly. The drop in AChR density after the ﬁrst 25 h (21 h
after removal of focal agrin) is consistent with a previous
ﬁnding that found complete dissipation of agrin-independent
clusters in C2C12 myotubes within 24 h after agrin (bath)
withdrawal (34). Clusters lose AChRs primarily because
AChRs are continuously targeted for degradation, but they
can also spontaneously diffuse laterally away from the
clusters. (In vivo, some are recycled back into the membrane,
but Bruneau and Akaaboune have shown that there is no
recycling of AChRs in C2C12 myotube cultures (34).)
Clusters incorporate primarily newly-synthesized AChRs,
but can also gain some by lateral diffusion from adjacent
membrane regions: in C2C12 myotubes cultured on laminin,
;9% recovery by lateral diffusion in 8 h has been observed
(30). The reason that in our experiments we do not see full
recovery of the agrin-exposed clusters after relabeling may
also be attributable to a suboptimal choice of agrin dose (as
the physiological dose is not known, we chose one previously
used in the literature) that only produces partial effects, and/
or to the lack of other signals from the axon tip that are not
present in the agrin stream. Future experiments are planned to
ﬁnd the agrin doses and other cell culture protocols that op-
timize the stability of protosynaptic AChRs.
Our microﬂuidic platform is similarly applicable to studies
of spatiotemporal competition between different focal stimuli
(several positions, onsets, and/or doses), exploring the role of
agrin as well as other factors involved in synaptogenesis such
as neuregulin and ACh.
SUPPLEMENTARY MATERIAL
To view all of the supplemental ﬁles associated with this
article, visit www.biophysj.org.
The authors are grateful to Drs. Marv Adams, Stanley Froehner, and Lisa F.
Horowitz for insightful comments and Dr. Greg Cooksey for assistance in
image analysis.
This work was funded by the National Institute of Biomedical Imaging and
Bioengineering under grant No. R01-EB001474.
REFERENCES
1. Cohen-Cory, S. 2002. The developing synapse: construction and
modulation of synaptic structures and circuits. Science. 298:770–776.
2. Kandel, E. R., J. H. Schwartz, and T. M. Jessel. 2000. The formation and
regeneration of synapses. In Principles of Neural Science. E. R. Kandel,
J. H. Schwartz, and T. M. Jessel, editors. McGraw-Hill, New York.
3. Dai, Z., and H. B. Peng. 2001. Fluorescent imaging of nicotinic
receptors during neuromuscular junction development. In Ion Channel
Localization: Methods and Protocols. A. N. Lopatin and C. G. Nichols,
editors. Humana Press, Totowa, NJ.
4. Anderson, M. J., and M. W. Cohen. 1977. Nerve-induced and spon-
taneous redistribution of acetylcholine receptors on cultured muscle
cells. J. Physiol. 268:757–773.
5. Lin, S., L. Landmann, M. A. Ruegg, and H. R. Brenner. 2008. The role
of nerve- versus muscle-derived factors in mammalian neuromuscular
junction formation. J. Neurosci. 28:3333–3340.
6. Frank, E., and G. D. Fischbach. 1979. Early events in neuromuscular
junction formation in vitro: induction of acetylcholine receptor clusters
in the postsynaptic membrane and morphology of newly formed
synapses. J. Cell Biol. 83:143–158.
7. Misgeld, T., T. T. Kummer, J. W. Lichtman, and J. R. Sanes. 2005.
Agrin promotes synaptic differentiation by counteracting an inhibitory
effect of neurotransmitter. Proc. Natl. Acad. Sci. USA. 102:11088–11093.
8. Flanagan-Steet, H., M. A. Fox, D. Meyer, and J. R. Sanes. 2005.
Neuromuscular synapses can form in vivo by incorporation of initially
aneural postsynaptic specializations. Development. 132:4471–4481.
9. Wang, Z. Z., A. Mathias, M. Gautam, and Z. W. Hall. 1999. Metabolic
stabilization of muscle nicotinic acetylcholine receptor by rapsyn.
J. Neurosci. 19:1998–2007.
10. McMahan, U. J. 1990. The agrin hypothesis. Cold Spring Harb. Symp.
Quant. Biol. 55:407–418.
11. Sanes, J. R., and J. W. Lichtman. 1999. Development of the vertebrate
neuromuscular junction. Annu. Rev. Neurosci. 22:389–442.
12. Bromann, P. A., H. Zhou, and J. R. Sanes. 2004. Kinase- and rapsyn-
independent activities of the muscle-speciﬁc kinase (MuSK). Neuro-
science. 125:417–426.
13. Cornish, T., D. W. Branch, B. C. Wheeler, and J. T. Campanelli. 2002.
Microcontact printing: a versatile technique for the study of synapto-
genic molecules. Mol. Cell. Neurosci. 20:140–153.
14. Tourovskaia, A., X. Figueroa-Masot, and A. Folch. 2006. Long-term
microﬂuidic cultures of myotube microarrays for high-throughput focal
stimulation. Nat. Protocols. 1:1092–1104.
15. Tourovskaia, A., X. Figueroa-Masot, and A. Folch. 2005. Differentiation-
on-a-chip: a microﬂuidic platform for long-term cell culture studies. Lab
Chip. 5:14–19.
16. Tourovskaia, A., T. F. Kosar, and A. Folch. 2006. Local induction of
acetylcholine receptor clustering in myotube cultures using micro-
ﬂuidic application of agrin. Biophys. J. 90:2192–2198.
17. Kosar, T. F., A. Tourovskaia, X. Figueroa-Masot, M. E. Adams, and A.
Folch. 2006. A nanofabricated planar aperture as a mimic of the nerve-
muscle contact during synaptogenesis. Lab Chip. 6:632–638.
18. Yang, X., S. Arber, C. William, L. Li, Y. Tanabe, T. M. Jessell, C.
Birchmeier, and S. J. Burden. 2001. Patterning of muscle acetylcholine
receptor gene expression in the absence of motor innervation. Neuron.
30:399–410.
19. Lin, W., R. W. Burgess, B. Dominguez, S. L. Pfaff, J. R. Sanes, and
K. F. Lee. 2001. Distinct roles of nerve and muscle in postsynaptic
differentiation of the neuromuscular synapse. Nature. 410:1057–1064.
20. Pun, S., M. Sigrist, A. F. Santos, M. A. Ruegg, J. R. Sanes, T. M.
Jessell, S. Arber, and P. Caroni. 2002. An intrinsic distinction in
neuromuscular junction assembly and maintenance in different skeletal
muscles. Neuron. 34:357–370.
21. Panzer, J. A., Y. Song, and R. J. Balice-Gordon. 2006. In vivo imaging
of preferential motor axon outgrowth to and synaptogenesis at
prepatterned acetylcholine receptor clusters in embryonic Zebraﬁsh
skeletal muscle. J. Neurosci. 26:934–947.
22. Tourovskaia, A., T. Barber, B. Wickes, D. Hirdes, B. Grin, D. Castner,
K. E. Healy, and A. Folch. 2003. Micropatterns of chemisorbed cell
adhesion-repellent ﬁlms using oxygen plasma etching and elastomeric
masks. Langmuir. 19:4754–4764.
23. Kummer, T. T., T. Misgeld, J. W. Lichtman, and J. R. Sanes. 2004.
Nerve-independent formation of a topologically complex postsynaptic
apparatus. J. Cell Biol. 164:1077–1087.
24. Tanford, C. 1961. Physical Chemistry of Macromolecules. Wiley, New
York.
25. Akaaboune, M., R. M. Grady, S. Turney, J. R. Sanes, and J. W.
Lichtman. 2002. Neurotransmitter receptor dynamics studied in vivo
by reversible photo-unbinding of ﬂuorescent ligands. Neuron. 34:865–
876.
Focal Agrin and AchR Cluster Dynamics 3015
Biophysical Journal 95(6) 3009–3016
26. Chen, H., E. Rhoades, J. S. Butler, S. N. Loh, and W. W. Webb. 2007.
Dynamics of equilibrium structural ﬂuctuations of apomyoglobin
measured by ﬂuorescence correlation spectroscopy. Proc. Natl. Acad.
Sci. USA. 104:10459–10464.
27. Andres, V., and K. Walsh. 1996. Myogenin expression, cell cycle
withdrawal, andphenotypic differentiationare temporally separable events
that precede cell fusion upon myogenesis. J. Cell Biol. 132:657–666.
28. Neville, C., N. Rosenthal,M.McGrew,N. Bogdanova, and S. Hauschka.
1997. Skeletal muscle cultures.Methods Cell Biol. 52:85–116.
29. Gesemann, M., A. J. Denzer, and M. A. Ruegg. 1995. Acetylcholine
receptor-aggregating activity of agrin isoforms and mapping of the
active site. J. Cell Biol. 128:625–636.
30. Bruneau, E. G., P. C. MacPherson, D. Goldman, R. I. Hume, and M.
Akaaboune. 2005. The effect of agrin and laminin on acetylcholine
receptor dynamics in vitro. Dev. Biol. 288:248–258.
31. Bursztajn, S., S. A. Berman, J. L. McManaman, and M. L. Watson.
1985. Insertion and internalization of acetylcholine-receptors at clus-
tered and diffuse domains on cultured myotubes. J. Cell Biol. 101:
104–111.
32. Bruneau, E., D. Sutter, R. I. Hume, and M. Akaaboune. 2005.
Identiﬁcation of nicotinic acetylcholine receptor recycling and its role
in maintaining receptor density at the neuromuscular junction in vivo.
J. Neurosci. 25:9949–9959.
33. Malinow, R., and R. C. Malenka. 2002. AMPA receptor trafﬁcking and
synaptic plasticity. Annu. Rev. Neurosci. 25:103–126.
34. Bruneau, E. G., and M. Akaaboune. 2006. The dynamics of recycled
acetylcholine receptors at the neuromuscular junction in vivo. Devel-
opment. 133:4485–4493.
35. Phillips, W. D., D. Vladeta, H. Han, and P. G. Noakes. 1997. Rapsyn
and agrin slow the metabolic degradation of the acetylcholine receptor.
Mol. Cell. Neurosci. 10:16–26.
36. Gervasio, O. L., and W. D. Phillips. 2005. Increased ratio of rapsyn to
ACh receptor stabilizes postsynaptic receptors at the mouse neuromus-
cular synapse. J. Physiol. 562:673–685.
37. Gervasio, O. L., P. F. Armson, and W. D. Phillips. 2007. Develop-
mental increase in the amount of rapsyn per acetylcholine receptor
promotes postsynaptic receptor packing and stability. Dev. Biol. 305:
262–275.
3016 Tourovskaia et al.
Biophysical Journal 95(6) 3009–3016
